Sixty Degree Capital
Robin joined Sixty Degree Capital in November 2019. Prior to joining, Robin worked for Toronto healthcare startups AmacaThera and Focal Healthcare in both business development and fundraising roles. Previously, Robin worked for ApoPharma’s pre-clinical research division as well as also performed HIV vaccines and MRI contrast agents research at the University of Toronto. Robin holds an MMI (Master of Management of Innovation) and H.B.Sc in Biological Chemistry from University of Toronto.
This person is not in any teams
This person is not in any offices
Sixty Degree Capital
1 followers
Sixty Degree Capital aims to search for companies with potential across three broad investment areas: Biopharmaceuticals, Healthcare platforms, Technology. They aim to remove the barriers between us and our potential in order to make present visions a reality.